• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     NIHR Horizon Scanning Centre (NIHR HSC) OncAlert® and SensoDX OraTech™ for the diagnosis of oral cancer
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Opportunities and strategies to drive appropriate use of MRI in Austria. Part 2]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Neurostimulation system for cluster headache]
2015     NIHR Health Technology Assessment programme Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data)
2015     Haute Autorite de sante (HAS) [Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection]
2015     NIHR Horizon Scanning Centre (NIHR HSC) ClearSight™ MRI for breast cancer lumpectomy
2015     NIHR Health Technology Assessment programme Tonsillectomy or adenotonsillectomy versus non-surgical management for sleep-disordered breathing in children
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Safety and efficacy of drug eluting balloon angioplasty for coronary artery stenosis: in-stent restenosis and de novo lesions]
2015     NIHR Public Health Research (PHR) programme Preventing alcohol misuse in young people: an exploratory cluster randomised controlled trial of the Kids, Adults Together (KAT) programme
2015     Haute Autorite de sante (HAS) [Assessment of diagnostic and therapeutic parotid and submandibular sialendoscopy]
2015     NIHR Health Technology Assessment programme Interventions for the treatment of oral and oropharyngeal cancers: immunotherapy
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [New and emerging health technologies 2015. Prioritized list]
2015     NIHR Health Services and Delivery Research programme What evidence is there on the effectiveness of different models of delivering urgent care? A rapid review
2015     Haute Autorite de sante (HAS) [Modification of the nomenclature of procedures in laboratory medicine for research into Treponema pallidum (bacteria responsible for syphilis)]
2015     NIHR Health Services and Delivery Research programme Collective action for knowledge mobilisation: a realist evaluation of the Collaborations for Leadership in Applied Health Research and Care
2015     Haute Autorite de sante (HAS) [Assessment of an edge-to-edge mitral valve repair clip and its implantation]
2015     NIHR Health Technology Assessment programme Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials)
2015     NIHR Health Technology Assessment programme Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
2015     Agency for Healthcare Research and Quality (AHRQ) Management and outcomes of binge-eating disorder
2015     Haute Autorite de sante (HAS) [Assessment of the safety and conditions for conducting autologous fat grafting in reconstructive, restorative and cosmetic breast surgery]
2015     NIHR Health Technology Assessment programme Active Treatment for Idiopathic Adolescent Scoliosis (ACTIvATeS): a feasibility study
2015     NIHR Health Technology Assessment programme Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Efficiency, effectiveness and safety of mechanical ventricular assistance with HeartWare® device in terminal heart failure]
2015     Haute Autorite de sante (HAS) [Alternative(s) to 99mTc-sestamibi preoperative scintigraphy for the localization of hypersecreting parathyroid glands in the event of complete shortage of 99mTechnetium (99mTc)]
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: β-ketothiolase deficiency (BKT); 3-hydroxy-3-methyl glutaric aciduria (HMG)]
2015     Agency for Healthcare Research and Quality (AHRQ) Nonpharmacological versus pharmacological treatments for adult patients with major depressive disorder
2015     Haute Autorite de sante (HAS) [Fractional flow reserve (FFR) measurement during coronary angiography]
2015     NIHR Health Technology Assessment programme A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS)
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Needs assessment and development of an information material for patients with sarcoidosis]
2015     NIHR Health Services and Delivery Research programme Integration and continuity of primary care: polyclinics and alternatives - a patient-centred analysis of how organisation constrains care co-ordination
2015     Haute Autorite de sante (HAS) [Measurement of nitric oxide (NO) in exhaled air]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Bevacizumab (Avastin®) in combination with chemotherapy as second-line therapy for HER2-negative, locally recurrent or metastatic breast cancer that has progressed after first-line treatment with bevacizumab plus chemotherapy
2015     National Institute for Health and Care Excellence (NICE) Repetitive transcranial magnetic stimulation for depression. NICE interventional procedures guidance 542
2015     NIHR Health Technology Assessment programme Systematic review of tools to measure outcomes for young children with autism spectrum disorder
2015     NIHR Health Services and Delivery Research programme Research utilisation and knowledge mobilisation in the commissioning and joint planning of public health interventions to reduce alcohol-related harms: a qualitative case design using a cocreation approach
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Biodegradable stents for the treatment of refractory or recurrent benign oesophageal stenoses]
2015     National Institute for Health and Care Excellence (NICE) Joint distraction for ankle osteoarthritis. NICE interventional procedures guidance 538
2015     Haute Autorite de sante (HAS) [Rare visceral surgery procedures by laparoscopy]
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nivolumab (Nivolumab BMS®) for the second-line therapy of metastatic squamous non-small cell lung cancer
2015     National Institute for Health and Care Excellence (NICE) Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma. NICE interventional procedures guidance 539
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ramucirumab in combination with paclitaxel as second-line treatment for adult patients with advanced gastric or gastro-oesophageal junction carcinoma
2015     Norwegian Institute of Public Health (NIPH) [Autologous hematopoietic stemcell transplantation (HSCT) for multiple sclerosis]
2015     National Institute for Health and Care Excellence (NICE) Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease. NICE interventional procedures guidance 540
2015     NIHR Health Technology Assessment programme A randomised controlled trial of the clinical effectiveness and cost-effectiveness of the levonorgestrel-releasing intrauterine system in primary care against standard treatment for menorrhagia: the ECLIPSE trial
2015     NIHR Health Technology Assessment programme A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)
2015     NIHR Health Services and Delivery Research programme Family-Reported Experiences Evaluation (FREE) study: a mixed-methods study to evaluate families' satisfaction with adult critical care services in the NHS
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Carfilzomib (Kyprolis®) for patients with relapsed multiple myeloma who have received one to three prior lines of therapy
2015     National Institute for Health and Care Excellence (NICE) Insertion of a subretinal prosthesis system for retinitis pigmentosa. NICE interventional procedures guidance 537
2015     NIHR Health Services and Delivery Research programme Delivering patient choice in clinical practice: a conversation analytic study of communication practices used in neurology clinics to involve patients in decision-making
2015     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of different strategies for screening for Chagas' disease in Spain]
2015     Health Information and Quality Authority (HIQA) Health technology assessment of a selective BCG vaccination programme
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Outpatient neurological rehabilitation: goal attainment in stroke patients. Systematic review]
2015     National Institute for Health and Care Excellence (NICE) Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes. NICE interventional procedures guidance 534
2015     NIHR Health Services and Delivery Research programme Multisite implementation of trained volunteer doula support for disadvantaged childbearing women: a mixed-methods evaluation
2015     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cost studies of type 2 diabetes: a review of literature]
2015     Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of a national screening programme for atrial fibrillation in primary care
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction - German short version and update of the correspondent EUnetHTA assessment]
2015     Norwegian Institute of Public Health (NIPH) A health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients
2015     National Institute for Health and Care Excellence (NICE) Living-donor liver transplantation. NICE interventional procedures guidance 535
2015     Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2015     Agency for Healthcare Research and Quality (AHRQ) Catheter ablation for treatment of atrial fibrillation
2015     Health Information and Quality Authority (HIQA) Health technology assessment of the use of information technology for early warning and clinical handover systems
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (MitraClip®, Carillon®, NeoChord DS1000). German short version of the correspondent EUnetHTA assessment]
2015     National Institute for Health and Care Excellence (NICE) Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention. NICE interventional procedures guidance 536
2015     Health Quality Ontario (HQO) Harms of Prostate-Specific Antigen (PSA) screening in prostate cancer: a rapid review
2015     NIHR Health Services and Delivery Research programme A systematic review and metaethnography to identify how effective, cost-effective, accessible and acceptable self-management support interventions are for men with long-term conditions (SELF-MAN)
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Pembrolizumab (Keytruda®) for the treatment of advanced melanoma
2015     Norwegian Institute of Public Health (NIPH) [Alternatives of plasma for transfusion to patients]
2015     National Institute for Health and Care Excellence (NICE) Implanting a baroreceptor stimulation device for resistant hypertension. NICE interventional procedures guidance 533
2015     Health Quality Ontario (HQO) Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015     NIHR Health Services and Delivery Research programme Integration and continuity of primary care: polyclinics and alternatives - a patient-centred analysis of how organisation constrains care co-ordination
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Robot-assisted surgery: a systematic review of effectiveness and safety for elected indications and accumulating costs]
2015     Norwegian Institute of Public Health (NIPH) Cost-effectiveness of HPV-vaccination of boys aged 12 in a Norwegian setting
2015     National Institute for Health and Care Excellence (NICE) Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer. NICE interventional procedures guidance 532
2015     NIHR Health Services and Delivery Research programme The Birthplace in England national prospective cohort study: further analyses to enhance policy and service delivery decision-making for planned place of birth
2015     Agency for Healthcare Research and Quality (AHRQ) Diagnosis of right lower quadrant pain and suspected acute appendicitis
2015     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [The effects of tangible and intangible incentives on health behaviour]
2015     National Institute for Health and Care Excellence (NICE) Preoperative high dose rate brachytherapy for rectal cancer. NICE interventional procedures guidance 531
2015     Blue Cross Blue Shield Association (BCBS) Special report: early intensive behavioral intervention and other behavioral interventions for autism spectrum disorder
2015     NIHR Health Services and Delivery Research programme Establishing and implementing best practice to reduce unplanned admissions in those aged 85 years and over through system change [Establishing System Change for Admissions of People 85+ (ESCAPE 85+)]: a mixed-methods case study approach
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Raltegravir (Isentress®)
2015     National Institute for Health and Care Excellence (NICE) Transcranial direct current stimulation (tDCS) for depression. NICE interventional procedures guidance 530
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eculizumab (Soliris®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sucroferric oxyhydroxide (Velphoro®)
2015     National Institute for Health and Care Excellence (NICE) Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section. NICE interventional procedures guidance 528
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ledipasvir/sofosbuvir (Harvoni®)
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tinzaparin sodium (Innohep®)
2015     National Institute for Health and Care Excellence (NICE) Joint distraction for knee osteoarthritis without alignment correction. NICE interventional procedures guidance 529
2015     National Institute for Health and Care Excellence (NICE) Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C. NICE medical technologies guidance 27
2015     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]
2015     University of York Supporting self-management: helping people manage long-term conditions
2015     NIHR Health Technology Assessment programme The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Denosumab (Xgeva®)
2015     National Institute for Health and Care Excellence (NICE) Suture fixation of acute disruption of the distal tibiofibular syndesmosis. NICE interventional procedures guidance 521
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tedizolid phosphate (Sivextro®)
2015     National Institute for Health and Care Excellence (NICE) Ultrasound-enhanced, catheter-directed thrombolysis for deep vein thrombosis. NICE interventional procedures guidance 523
2015     University of York Promoting patient-centred care planning consultations
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Insulin glargine (Abasaglar®)
2015     National Institute for Health and Care Excellence (NICE) Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism. NICE interventional procedures guidance 524
2015     National Institute for Health and Care Excellence (NICE) Tegaderm CHG securement dressing for vascular access sites in critically ill adults. NICE medical technologies guidance 25